Hey Jane Health Revenue and Competitors

Location

#2502

Growjo Ranking

Health

Industry

Estimated Revenue & Valuation

  • Hey Jane Health's estimated annual revenue is currently $36.7M per year.(i)
  • Hey Jane Health's estimated revenue per employee is $270,000

Employee Data

  • Hey Jane Health has 136 Employees.(i)
  • Hey Jane Health grew their employee count by 46% last year.

Hey Jane Health's People

NameTitleEmail/Phone
1
Co-founder & CEOReveal Email/Phone
2
Director Clinical Quality and SafetyReveal Email/Phone
3
RN Clinical AdministratorReveal Email/Phone
4
Senior Patient Care AdvocateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M330%N/AN/A
#2
$21.3M797%N/AN/A
#3
$387.8M1026-2%N/AN/A
#4
$0.2M8-27%N/AN/A
#5
$3.1M19-10%N/AN/A
#6
$5.3M284%N/AN/A
#7
$2.6M16-48%N/AN/A
#8
$9.7M457%N/AN/A
#9
$8.4M398%N/AN/A
#10
$10.4M489%N/AN/A
Add Company

What Is Hey Jane Health?

At the corner of technology and women's health, Hey Jane provides reliable, accessible abortion care that empowers women to lead better lives.

keywords:N/A

N/A

Total Funding

136

Number of Employees

$36.7M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Hey Jane Health News

2022-04-17 - Why Google and Facebook Keep Shutting Down Abortion Pill ...

Women's healthcare startup Hey Jane spent more than a year running ads on Google promoting its services providing abortion pills by mail.

2022-03-30 - Online Abortion Care Provider Hanna Kim of Hey Jane ...

Hey Jane provides medication abortion up to 10 weeks of pregnancy to ... I have been a nurse for almost 10 years now in reproductive health,...

2022-03-22 - The FDA made mail-order abortion pills legal. Access is still a nightmare.

Emma, who is well-versed in reproductive health care, ... For example, Hey Jane guarantees patients will see a physician within 36 hours,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$43.9M13626%N/A
#2
$16.3M13626%N/A
#3
$7.5M1366%N/A
#4
$34M13615%N/A
#5
$19M13616%N/A